業績紹介

業績紹介

2019年

[原著(英文)]
Wendt H, Abry P, Kiyono K, Hayano J, Watanabe E, Yamamoto Y.
Wavelet p-leader non- Gaussian multiscale expansions for heart rate variability analysis in congestive heart failure patients.
IEEE Trans Biomed Eng. 2019; 66(1): 80-8.
Amino M, Yoshioka K, Ichikawa T, Watanabe E, Kiyono K, Nakamura M, Sakama S, Ayabe K, Fujii T, Hashida T, Kanda S, Tanabe T and Ikari Y.
The presence of late potentials after percutaneous coronary intervention for the treatment acute coronary syndrome as a predictor for future significant cardiac events resulting in re-hospitalization.
J Electrocardiol. 2019; 53:71-8.
Kawai M, Harada M, Motoike Y, Koshikawa M, Ichikawa T, Watanabe E, Ozaki Y.
Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: A prospective cohort study.
Int J Cardiol Heart Vasc. 2019; 22: 111-6.
Yamamoto M, Okajima K, Shimane A, Ozawa T, Morishima I, Asai T, Takagi M, Kasai A, Fujii E, Kiyono K, Watanabe E, Ozaki Y.
A decision Tree-Based Survival Analysis of Patients with a History of Inappropriate Implantable Cardioverter-Defibrillator Therapy.
Int Heart J. 2019; 60(2): 318-26.
Okishige K, Yamauchi Y, Hanaki Y, Inoue K, Tanaka N, Yamaji H, Murakami T, Manita M, Tabata K, Ooie T, Tatsukawa Y, Sakai H, Yamaki M, Murakami M, Takada T, Osaka Y, Ono Y, Handa K, Sugiyama K, Yoshizawa T, Fukaya H, Tashiro H, Takase S, Harada M, Watanabe E, Yamane T, Yamashita S, Aonuma K.
Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation.
J Thromb Thrombolysis. 2019 Apr 6. doi: 10.1007/s11239-019-01835-8. [Epub ahead of print]